The move to a virtual meeting platform is not the only thing new about the 2020 San Antonio Breast Cancer Symposium. Alongside all of the cutting-edge educational programming, late-breaking science and networking opportunities you’ve come to expect, day one of this year’s Symposium includes a number of exciting and timely new offerings you won’t want to miss. Check the online program or mobile app for the most up-to-date Symposium schedule.

Tuesday, December 8
8:15 am – 11:00 am
SPECIAL SESSION: Setting the Stage for Health Equity, Collaboration and Partnership
Presented by Tigerlily Foundation & AACR

• Socio-Economic Access Matters
• Not a One Size Fits All: Personalized Medicine for the Underserved
• Policy Change to End Disparities

SPECIAL SESSION: Breast Cancer Care During COVID-19: How Did Patients and Clinicians Respond – A Global Perspective

• Confronting Inequities of Care
• Living With Breast Cancer and COVID-19
• Global Perspectives on Breast Cancer Care During the COVID-19 Pandemic and How BC was Managed and Lessons Learned

9:30 am – 11:00 am
FDA and Breast Cancer Workshop

• Sacituzumab
  Christy Osgood, MD, US Food and Drug Administration

• Trastuzumab Deruxtecan
  Preeti Narayan, MD, US Food and Drug Administration

• Tucatinib
  Mirat Shah, MD, US Food and Drug Administration

Global Breast Cancer Screening

• Breast cancer screening trials in low and middle income countries: Lessons learned
  Rengaswamy Sankaranarayanan, MD, MBBS

• Weighing the benefits and harms of breast cancer screening
  Philippe Autier, MD, MPH, PhD